4-Hydroxytamoxifen: Technical Parameters for Lab Research

What This Product Solves

4-Hydroxytamoxifen (4-OHT) addresses the need for a reliable, high-purity estrogen receptor modulator in cell-based and in vivo research settings. Its primary use is in experimental models where selective stimulation or inhibition of estrogen receptors is required, supporting studies in breast cancer research, prostate cancer research, apoptosis assays, and cardiac myocyte calcium handling studies. The compound is supplied at ~98% purity, verified by HPLC and NMR, ensuring reproducibility when workflow and storage practices are rigorously followed. Unlike many alternatives, 4-Hydroxytamoxifen is formulated specifically for DMSO-based solubilization, eliminating solubility variability common with ethanol or aqueous protocols.

For technical workflow guidance and solvent compatibility, see also 4-Hydroxytamoxifen: Technical Use and Protocol Guidance, which elaborates on key storage and preparation steps, and 4-Hydroxytamoxifen: Protocol Guidance and Workflow QC for further discussion of solubility limitations and DMSO protocol optimization.

Protocol Parameters

• Assay: Solubility in DMSO
  Value: ≥42 mg/mL
  Applicability: All in vitro and in vivo workflows requiring concentrated stock solutions
  Rationale: Enables preparation of high-concentration stocks without precipitation, supporting reproducible dosing.
  Source Type: Product information
• Assay: Storage temperature (solid form)
  Value: -20°C
  Applicability: Required for long-term storage of unopened or re-capped solid material
  Rationale: Prevents degradation and preserves chemical integrity between experiments.
  Source Type: Product information
• Assay: Solvent compatibility
  Value: Insoluble in ethanol and water
  Applicability: Protocol design and solvent selection
  Rationale: Avoids incomplete dissolution, precipitation, and inconsistent dosing in incompatible media.
  Source Type: Product information
• Assay: Solution storage duration
  Value: Avoid long-term storage of DMSO solutions (use fresh or aliquot and freeze briefly)
  Applicability: All workflows requiring stock solutions
  Rationale: Minimizes compound degradation, supporting batch-to-batch consistency.
  Source Type: Workflow recommendation

Workflow Setup and QC Checklist

• Material inspection: Upon receipt, verify label, SKU (B6167), appearance, and store immediately at -20°C to maintain purity.
• Weighing and handling: Perform all weighing in a low-humidity environment to prevent moisture uptake; use analytical-grade balances for accuracy, and wear gloves to avoid contamination.
• Stock solution preparation: Dissolve only in anhydrous DMSO at concentrations up to or above 42 mg/mL. Vortex thoroughly; confirm full dissolution visually before aliquoting.
• Aliquoting and storage: Prepare aliquots to minimize freeze-thaw cycles; store at -20°C. Label aliquots with preparation date and concentration. Discard solutions if precipitation or discoloration occurs.
• Working dilutions: Prepare fresh dilutions into compatible media immediately prior to use, ensuring DMSO content remains within cell or animal model tolerance limits.
• QC for reproducibility: Track lot numbers, solution age, and handling conditions in laboratory records; repeat key controls when working with new batches or preparations.

Common Failure Modes and Fixes

• Incomplete dissolution: If solid persists after vortexing in DMSO, gently warm (not exceeding 37°C) and continue mixing. Do not attempt to dissolve in ethanol or water due to insolubility.
• Precipitation after storage: If precipitate forms in stored DMSO solutions, discard and prepare a fresh stock. Avoid storing working solutions for extended periods.
• Loss of activity: Degradation can occur if stored above -20°C or exposed to repeated freeze-thaw cycles. Always aliquot and minimize repeated handling.
• Batch-to-batch variability: Confirm each new lot’s purity and solubility as described; maintain detailed preparation and usage logs for traceability.
• Cell or tissue toxicity from DMSO: Ensure DMSO concentration in final working solutions does not exceed recommended thresholds for your biological system.

Scope and Limitations

4-Hydroxytamoxifen is specifically engineered for DMSO-based protocols in laboratory research related to estrogen receptor modulation. It is suitable for breast cancer research, prostate cancer research, apoptosis assays, and cardiac myocyte calcium handling studies where precise control over receptor activity is critical. The product is not compatible with workflows requiring ethanol or aqueous solvents, and improper storage or handling can lead to loss of activity and irreproducible results. Applications outside these well-established research domains, or those requiring alternative solvents, fall outside the validated scope of this reagent.

Conclusion

4-Hydroxytamoxifen (SKU B6167, APExBIO) is a rigorously validated estrogen receptor modulator optimized for DMSO-based laboratory protocols. Proper application in breast and prostate cancer models, apoptosis studies, and cardiac myocyte assays depends on adherence to solubility, storage, and workflow best practices. Adhering to these technical parameters ensures reliability and reproducibility across sensitive research applications.